NASDAQ:ISEE
Delisted
IVERIC bio Inc. Stock News
$39.95
+0 (+0%)
At Close: Oct 09, 2023
IVERIC bio Appoints Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officer
08:01pm, Monday, 23'rd Mar 2020
IVERIC bio, Inc. announced the appointment of Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officer.
Coronavirus pandemic leads big drugmakers to hit pause on clinical trials
07:29pm, Monday, 23'rd Mar 2020
U.S. drugmakers Eli Lilly and Co and Bristol Myers Squibb said they are delaying...
UPDATE 3-Coronavirus pandemic leads big drugmakers to hit pause on clinical trials
07:23pm, Monday, 23'rd Mar 2020
U.S. drugmakers Eli Lilly and Co and Bristol Myers Squibb said they are delaying...
Coronavirus begins disrupting clinical trials as companies try containing spread
03:39pm, Wednesday, 18'th Mar 2020
U.S.-based Iveric bio Inc delayed enrolment in a trial of its eye disease drug on Wednesday, two days after Provention Bio paused a study of its diabetes drug but allowed trial patients to complete th
UPDATE 2-FDA urges virtual patient visits as coronavirus disrupts clinical trials
03:37pm, Wednesday, 18'th Mar 2020
The U.S. Food and Drug Administration on Wednesday recommended switching to virt...
UPDATE 1-Coronavirus begins disrupting clinical trials as companies try containing spread
01:59pm, Wednesday, 18'th Mar 2020
U.S.-based Iveric bio Inc on Wednesday became the latest company to delay a clin...
U.S. companies begin delaying clinical trials due to coronavirus outbreak
12:51pm, Wednesday, 18'th Mar 2020
U.S.-based Iveric bio Inc on Wednesday became the latest company to delay a clin...
IVERIC bio announced that due to the threat of COVID-19, the Company decided to delay enrollment in the second pivotal clinical trial for Zimura®.
IVERIC bio Reports Fourth Quarter and Year End 2019 Operational Highlights and Financial Results
12:00pm, Thursday, 27'th Feb 2020
IVERIC bio, Inc. announced financial and operating results for the fourth quarter and full year ended December 31, 2019 and provided a business update
Iveric bio: Much More Upside Ahead
01:16am, Wednesday, 12'th Feb 2020
Zimura stands to be a game-changer in the dry AMD indication. There are other promising assets in the company’s pipeline. Investors should consider these risks.
Allergan Reports Q4 Earnings Beat
12:00am, Monday, 10'th Feb 2020
Allergan plc (NYSE: AGN) reported quarterly earnings of $5.22 per share on Monday, beating the analyst consensus estimate of $4.57 by 14.22%.
This is a 21.68% increase over...
Wedbush Starts Iveric Bio Coverage With Bullish Rating On Zimura's Upcoming Pivotal Study
05:26pm, Tuesday, 07'th Jan 2020
Geographic atrophy is estimated to represent a market opportunity of over $1 billion, with the current patient population at more than 1 million, Nierengarten said in the note. In October, Iveric Bio
Hedge Funds Dropped The Ball On IVERIC bio, Inc. (ISEE)
12:58am, Tuesday, 24'th Dec 2019
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we've gathered as a result gives
Why Is IVERIC bio (ISEE) Up 79.1% Since Last Earnings Report?
04:30pm, Thursday, 12'th Dec 2019
IVERIC bio (ISEE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend
12:39pm, Friday, 06'th Dec 2019
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 5) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD )(present
